Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death

Background. Evidence is sparse regarding the optimal construction of regimens to treat multidrug-resistant (MDR) tuberculosis disease due to strains of Mycobacterium tuberculosis resistant to at least both isoniazid and rifampin. Given the low potency of many second-line antituberculous drugs, we hy...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Infect Dis
मुख्य लेखकों: Velásquez, Gustavo E., Becerra, Mercedes C., Gelmanova, Irina Y., Pasechnikov, Alexander D., Yedilbayev, Askar, Shin, Sonya S., Andreev, Yevgeny G., Yanova, Galina, Atwood, Sidney S., Mitnick, Carole D., Franke, Molly F., Rich, Michael L., Keshavjee, Salmaan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2014
विषय:
Articles and Commentaries
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305127/
https://ncbi.nlm.nih.gov/pubmed/24729493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu209
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन